SEE ALSO...
Items 11 to 20 of 21 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
NSAID that might modulate leukotriene pathway, affecting CysLT1 receptor. | ||||||
Montelukast Dicyclohexylamine Salt | 577953-88-9 | sc-211923 | 1 mg | $320.00 | ||
Montelukast Dicyclohexylamine Salt functions as a selective antagonist of the CysLT1 receptor, exhibiting unique binding dynamics that disrupt leukotriene signaling. Its structural conformation facilitates specific electrostatic interactions, enhancing receptor affinity. The compound's kinetic profile reveals a notable balance between binding strength and dissociation, allowing for transient modulation of receptor states. Additionally, its amphiphilic nature promotes effective integration into lipid bilayers, influencing membrane-associated processes. | ||||||
Pranlukast hemihydrate | 150821-03-7 | sc-215745 | 5 mg | $73.00 | ||
Pranlukast hemihydrate acts as a selective antagonist of the CysLT1 receptor, characterized by its unique ability to stabilize receptor conformations through specific hydrophobic interactions. This compound exhibits a distinct kinetic behavior, with a rapid association rate that allows for effective competition against endogenous ligands. Its solubility properties enhance its distribution in biological systems, facilitating interactions with membrane proteins and influencing downstream signaling pathways. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $41.00 | 4 | |
Can alter leukotriene synthesis, potentially influencing CysLT1 receptor. | ||||||
Montelukast-d6, Sodium Salt | sc-218876 | 1 mg | $331.00 | |||
Montelukast-d6, Sodium Salt functions as a selective antagonist of the CysLT1 receptor, exhibiting unique binding dynamics that involve intricate hydrogen bonding and electrostatic interactions. This compound demonstrates a notable affinity for the receptor, leading to a prolonged dissociation time that enhances its competitive inhibition of leukotriene signaling. Its isotopic labeling provides insights into metabolic pathways, allowing for advanced tracking in biochemical studies. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
Might have an indirect impact on leukotriene pathway and CysLT1 receptor. | ||||||
Naproxen | 22204-53-1 | sc-200506 sc-200506A | 1 g 5 g | $24.00 $40.00 | ||
NSAID that may affect leukotriene synthesis, influencing CysLT1 receptor. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Corticosteroid that can modulate inflammatory pathways affecting CysLT1 receptor. | ||||||
Prednisone | 53-03-2 | sc-205816 sc-205816A sc-205816B | 1 g 5 g 25 g | $41.00 $133.00 $663.00 | 2 | |
Can influence leukotriene pathway, potentially affecting CysLT1 receptor. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Might modulate leukotriene synthesis and CysLT1 receptor activity. |